- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Earnings
see more| Q3 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.560 | -0.650 | -0.0900 | ||||
| REV | 2.880M | 3.039M | 159.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Eiger BioPharmaceuticals Questions & Anwsers
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), AVEO Pharmaceuticals (NASDAQ:AVEO), Impel NeuroPharma (NASDAQ:IMPL), OncoCyte (NASDAQ:OCX) and Celcuity (NASDAQ:CELC).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by Citigroup on August 9, 2021. The analyst firm set a price target for 27.00 expecting EIGR to rise to within 12 months (a possible 360.75% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $5.86 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s $Q3 earnings are confirmed for after-market on November 4, 2021.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.